Celltrion reported KRW230.8B in Ordinary Share Capital for its fiscal quarter ending in March of 2025.


Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2K 0 Dec/2024
Celltrion KRW 230.8B 10.29B Mar/2025
Dianthus Therapeutics USD 32.18M 32.15M Jun/2025
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
IQVIA Holdings USD 170M 167.42M Jun/2025
Moderna USD 389M 388.96M Jun/2025
Organon & Co USD 259.96M 256.96M Jun/2025
Revvity USD 117.87M 2.78M Jun/2025
Tectonic Therapeutic USD 18.71M 18.71M Jun/2025
Viatris USD 1.17B 1.15B Jun/2025
Xeris Pharmaceuticals USD 161.22M 161.21M Jun/2025